Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Animal Bites : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
Multimedia
References

Related Articles
Arthritis, Septic

Human Bites

Osteomyelitis

Rabies

Tetanus




Patient Education
Bites and Stings Center

Bacterial and Viral Infections Center

Animal Bites Overview

Animal Bites Causes

Animal Bites Symptoms

Animal Bites Treatment

Rabies Overview




Author: Clifford S Spanierman, MD, Consulting Staff, Departments of Emergency Medicine and Pediatrics, Lutheran General Hospital of Oak Brook, Advocate Health System

Editors: Harold K Simon, MD, MBA, Professor of Pediatrics and Emergency Medicine, Associate Division Director of Pediatric Emergency Medicine, Director of Research, Division of Pediatric Emergency Medicine, Emory University School of Medicine, Children's Healthcare of Atlanta at Egleston; Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc; Wayne Wolfram, MD, MPH, Clinical Associate Professor, Departments of Pediatrics, Children's Hospital and University of Cincinnati; Paul D Petry, DO, FACOP, FAAP, Consulting Staff, Freeman Pediatric Care, Freeman Health System; Russell W Steele, MD, Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Author and Editor Disclosure

Synonyms and related keywords: animal bites, dog bites, cat bites, bite-related infection, mammal bites, rodent bites, ferret bites, rabbit bites, pit bull bite, pet bites, bite wound infection, cellulitis, rabies, septic arthritis, animal bites, Staphylococcus, Streptococcus, Pasteurella, Bacteroides, Capnocytophaga canimorsus, Eikenella, Enterobacter, Proteus, Haemophilus, Klebsiella, Actinomyces, Fusobacterium, Peptostreptococcus, Clostridium, Wolinella, Propionibacterium, osteomyelitis

Background

Estimates indicate that more than 5 million Americans are bitten by animals each year. Dogs and cats are involved in most of these bites. Bites from both cats and dogs require careful management, and patients may experience long-term morbidity or may even die. Cat bites have a high incidence of infection (approximately 50%), and dog bites may cause severe injury to tissues. Dog and cat populations in the United States are each estimated to exceed 50 million animals. Many households in the United States include pets, and many children are bitten by family pets.

Breeds associated with serious dog bites in children include pit bull, Rottweiler, wolf mix, Saint Bernard, German Shepherd, and Akita.

Pathophysiology

Dogs and cats have prominent canine teeth; however, great differences are observed in the structure of those teeth. Dogs have wider canines, while cats have thinner canines. Dogs are capable of exerting enormous pressure when biting, and some breeds can pierce metal plates with their teeth. In particular, the bites of large dogs can be dangerous to children. Large breeds tend to cause wounds in the head and neck areas of younger children, and their powerful jaws can penetrate the skull and destroy deep tissue. Cat bites are characterized by puncture wounds that inoculate bacteria deep into tissues.

Cats and dogs harbor a number of potentially pathogenic species of aerobic and anaerobic bacteria in the oral flora.1 Common genera include Staphylococcus, Streptococcus, Pasteurella, and Bacteroides.2 Other organisms cultured in dog bites include Capnocytophaga canimorsus and species of Eikenella, Enterobacter, Proteus, Haemophilus, and Klebsiella. Cat bites may contain Actinomyces, Fusobacterium, Peptostreptococcus, Clostridium, Wolinella, and Propionibacterium organisms. Infections should be assumed to be polymicrobial.

Frequency

United States

Estimates indicate that more than 5 million Americans are bitten by animals each year. Dog bites account for nearly 85% of the total number of animal bites, and cat bites for approximately 10%. Other animals involved in bites include rodents and other small mammals, such as ferrets and rabbits. Bites from more exotic animals (eg, snakes, lizards, monkeys, farm animals) are rare.

International

Types of animal bites can vary depending on land development and the natural flora. For example, in India, tiger bites may be encountered. In general, in North America, dogs are the agents in most animal bites.

Mortality/Morbidity

Each year, approximately 20 people die as a result of dog bites; most of these people are young children who have massive neck and head injuries resulting from the bites. The mouths in breeds of large dogs are at the height of young children's faces. Pit bulls, with powerful jaws that are capable of causing rapid and devastating damage, are responsible for nearly three fourths of all dog bite fatalities.

  • Wound infection and cellulitis resulting from bacterial infections are the most common causes of morbidity.
  • Bite wounds in joint spaces may be complicated by septic arthritis. Deep wounds may be complicated by osteomyelitis, and penetrating skull wounds may result in meningitis.
  • Although rare, rabies can be a fatal complication of mammalian bites. The possibility of rabies should be addressed in the history.
  • Puncture wounds have a higher rate of infection than lacerations. However, lacerations cause more damage to tissues.

Sex

Males are more likely than females to be bitten by dogs.3 Females are more likely than males to be bitten by cats.

Age

Animal bites are most common in children aged 5-14 years.



History

Begin taking the history with prehospital care.

  • Important details in the history include the type of animal that attacked the patient, behavior of the animal, and time of day the bite occurred. For instance, a raccoon bite in the daytime places the patient at higher risk of rabies exposure, as does an unprovoked attack.
  • Document the address or location of the attack and the time of the attack (important).
  • Ascertain ownership of the animal, current location of the animal, and rabies vaccination status.
  • Document prehospital care (eg, wound cleansing).
  • Document the patient's allergies, current medications, medical history, immunization status, and the time of the last meal.

Physical

  • Focus physical examination initially on the ABCs.
    • Patients with animal bites rarely require resuscitation.
    • Ensure that no compromise of circulation, motor skills, or sensation is present.
    • Inspect the wounds, paying careful attention to soft tissue damage, tendon exposure or injury, bone exposure, and the presence of foreign bodies.
  • Limitations of the physical examination are as follows:
    • Cat bites may appear innocuous but may violate joint space integrity.
    • Dog bites to the head may penetrate the skull, and foreign bodies (eg, teeth, fragments of teeth) may not be detected upon examination.

Causes

Bites may be either provoked or unprovoked.

  • Causes of provoked attacks
    • Antagonizing an animal
    • Hurting an animal
  • Causes of unprovoked attacks
    • Approaching the young of an animal
    • Approaching an animal that is eating
    • Entering the property of a territorial animal
    • Nearing an animal with rabies
  • Dogs are pack animals. Many instances have occurred in which individuals were mauled by packs.



Arthritis, Septic
Human Bites
Osteomyelitis
Rabies
Tetanus

Other Problems to be Considered

Wound infection
Cellulitis
Fractures
Foreign bodies
Meningitis
Cervical spine injury
Vascular injury



Lab Studies

  • Laboratory testing is rarely helpful when patients with dog bites present immediately after injury. Patients who are hemodynamically unstable are an obvious exception.
  • Additional laboratory testing should be performed as indicated. Usually, patients who present with infection require further workup.
    • Consider obtaining a tissue culture in patients who do not have sepsis when presenting with a wound infection.
    • Obtain a CBC count and blood culture in patients with more severe infections.

Imaging Studies

  • Radiography is generally not helpful but may be useful for certain bite wounds.
  • Dog bites to the head may penetrate the skull. At the minimum, perform skull radiography in a child with a dog bite to the head, especially with a bite from a large dog.
  • Foreign bodies, such as tooth fragments, may be revealed by radiography. Perform radiography if the possibility of a foreign body cannot be excluded by examination.
  • Patients with deep tissue injuries may have fractures. The hand and joint spaces are particularly vulnerable.
  • Patients who present with signs of infection may have osteomyelitis or septic arthritis. Bone scans may reveal osteomyelitis even in patients in whom radiography findings are negative.
  • Perform head CT scanning in children with penetrating skull injuries.

Procedures

  • Joint aspiration may aid in the diagnosis of septic arthritis.



Medical Care

  • Address ABCs immediately in the event of facial and neck wounds.
  • Wounds should be copiously irrigated with isotonic sodium chloride solution under high pressure (usually with an 18- or 19-gauge needle or angiocatheter). Wounds may require more than 200 mL/in of isotonic sodium chloride solution.
  • Infection is a feared complication of animal bites, especially cat bites. Studies have shown that infections are polymicrobial. Antibiotic coverage for staphylococci and anaerobes is necessary.
  • Consider tetanus prophylaxis.
  • Consider rabies prophylaxis in certain circumstances (eg, raccoon bites, bat bites, unprovoked attack by an unknown animal).

Surgical Care

Surgical treatment may be appropriate.

  • Debridement is useful for removing foreign bodies and devitalized tissue, which can serve as a nidus for infection. Remove blood clots, and inspect the wound further during the procedure.
  • Careful wound excision may improve the cosmetic appearance of the scar and decrease the incidence of wound infection.
  • Perform primary closure in certain wounds. Facial wounds rarely become infected because the face is well vascularized. Clean wounds can also be closed. Wounds on the hands or lower extremities should be left open. Patients who have a wound older than 6 hours are best treated using delayed primary closure in lieu of primary closure.

Consultations

  • Plastic surgeon for potentially disfiguring injuries
  • Hand specialist for injuries to the hand
  • Orthopedist for bone and joint injuries or deep structural injuries
  • Neurosurgeon for penetrating wounds to the skull
  • Vascular specialist for neck wounds
  • Infectious disease specialist for immunocompromised patients



Amoxicillin combined with a beta-lactamase inhibitor is the most commonly used oral antibiotic. Patients who are allergic to penicillin and are tolerant of cephalosporins may be treated with ceftriaxone. Patients who are intolerant to cephalosporins may be treated with a combination of trimethoprim and sulfamethoxazole plus clindamycin. Prophylaxis may also be provided with erythromycin or a tetracycline. A 3- to 7-day course of antibiotic therapy is commonly used for prophylaxis.

Drug Category: Antibiotics

These agents are used for prophylaxis and treatment of infection. Empiric antimicrobial therapy must be comprehensive and should cover all likely pathogens in the context of the clinical setting.

Drug NameAmoxicillin clavulanate (Augmentin)
DescriptionCombination antibiotic containing amoxicillin with a beta-lactamase inhibitor, which extends the antibiotic spectrum. Overall, the spectrum of this antibiotic provides the best prophylaxis against potential pathogens. Dose is based on the amoxicillin content.
Adult Dose500 mg PO tid or 875 mg PO bid
Pediatric Dose<3 months: 30-40 mg/kg/d PO divided bid (use 125 mg/5 mL susp)
>3 months: 45 mg/kg/d PO divided q12h (use 200 or 400 mg/5 mL susp)
If 125 or 250 mg/5mL susp is used, administer 40 mg/kg/d PO divided q8h
ContraindicationsDocumented hypersensitivity; prior Augmentin-induced hepatic dysfunction
InteractionsCoadministration with warfarin or heparin increases risk of bleeding; probenecid may inhibit renal tubular secretion of amoxicillin, thus increasing levels
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsCaution in liver dysfunction and pseudomembranous colitis; administer with food; common adverse reactions include rash and gastrointestinal tract upset

Drug NameAmpicillin-sulbactam (Unasyn)
DescriptionTreatment of choice for infected bites with a spectrum similar to Augmentin. Contains two-thirds ampicillin and one-third sulbactam. Pediatric doses are based on ampicillin component.
Adult Dose1.5 g (1 g ampicillin plus 0.5 g sulbactam) IV q6h
Pediatric Dose100-150 ampicillin/kg/d IV divided q6h
ContraindicationsDocumented hypersensitivity
InteractionsProbenecid and disulfiram elevate ampicillin levels; allopurinol decreases ampicillin effects and has additive effects on ampicillin rash; may decrease effects of PO contraceptives
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsPseudomembranous colitis; evaluate rash and differentiate from hypersensitivity reaction; adjust dose in renal failure

Drug NameTrimethoprim and sulfamethoxazole (Bactrim, Septra)
DescriptionUsed in combination with clindamycin for prophylaxis or treatment in patients allergic to penicillin.
Sulfamethoxazole inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid. Trimethoprim blocks the production of tetrahydrofolic acid by inhibiting the enzyme dihydrofolate reductase. Two consecutive steps in bacterial biosynthesis of essential nucleic acids and proteins are blocked with this combination. In vitro bacterial resistance is slower to develop with this combination than with either drug alone.
Adult Dose160 mg trimethoprim/800 mg sulfamethoxazole PO q12h (ie, 1 double-strength tab q12h)
Pediatric Dose<2 months: Do not administer
>2 months: 8-10 mg/kg/d (based on trimethoprim component) PO divided q12h
ContraindicationsDocumented hypersensitivity; anemia caused by folate deficiency
InteractionsMay increase PT when used with warfarin (perform coagulation tests and adjust dose accordingly); coadministration with dapsone may increase blood levels of both drugs; coadministration with diuretics increases incidence of thrombocytopenia purpura in elderly patients; phenytoin levels may increase with coadministration; may potentiate effects of methotrexate in bone marrow depression; hypoglycemic response to sulfonylureas may increase with coadministration; may increase levels of zidovudine
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsDo not use in pregnancy near term (risk of kernicterus); may cause Stevens-Johnson syndrome and toxic epidermal necrolysis; discontinue at first appearance of rash or signs of adverse reaction (eg, rash, sore throat, fever, arthralgia, cough, shortness of breath, pallor, purpura, jaundice); hepatic necrosis; aplastic anemia; agranulocytosis; hemolysis may occur in patients with G-6-PD deficiency (dose related); caution in renal or hepatic impairment

Drug NameClindamycin (Cleocin)
DescriptionUsed for prophylaxis and treatment of animal bites in combination with trimethoprim/sulfamethoxazole; inhibits bacterial protein synthesis by its action at the bacterial ribosome; binds to 50S ribosomal subunit and affects process of peptide chain initiation.
Adult Dose150-450 mg PO q6-8h
1200-1800 mg IV divided tid/qid
Pediatric Dose10-30 mg/kg/d PO divided tid/qid
25-40 mg/kg/d IV divided q6-8h
ContraindicationsDocumented hypersensitivity; regional enteritis; ulcerative colitis; hepatic impairment; antibiotic-associated colitis
InteractionsIncreases duration of neuromuscular blockade induced by tubocurarine and pancuronium; erythromycin may antagonize effects of clindamycin; antidiarrheals may delay absorption of clindamycin
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsPseudomembranous colitis; adjust dose in severe hepatic dysfunction; no adjustment necessary in renal failure; advise patients to take cap with full glass of water

Drug NameErythromycin (EES, E-Mycin, Ery-Tab, Erythrocin)
DescriptionFor prophylactic use in patients allergic to penicillin; macrolide antibiotic with a large spectrum of activity; binds to 50S ribosomal subunit to inhibit protein synthesis.
Adult Dose250-500 mg PO qid or 400-800 mg (ethylsuccinate) PO tid
Pediatric Dose30-50 mg/kg/d PO divided q6-8h
ContraindicationsDocumented hypersensitivity; hepatic impairment; concomitant administration of terfenadine (recalled from US market), cisapride, or astemizole (recalled from US market)
InteractionsDecreases clearance of terfenadine (recalled from US market), cisapride, and astemizole (recalled from US market), which may result in serious cardiac arrhythmias; decreases clearance of cyclosporine, midazolam, phenytoin, triazolam, theophylline, and carbamazepine; may increase warfarin toxicity
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsImpaired hepatic function, abdominal pain, diarrhea, nausea, and vomiting

Drug NameCeftriaxone (Rocephin)
DescriptionThird-generation cephalosporin with broad-spectrum gram-negative activity; lower efficacy against gram-positive organisms; higher efficacy against resistant organisms. Arrests bacterial growth by binding to one or more penicillin-binding proteins.
Adult DoseUncomplicated infections: 250 mg IM once; not to exceed 4 g
Severe infections: 1-2 g IV qd or divided bid; not to exceed 4 g/d
Pediatric DoseNeonates >7 days: 25-50 mg/kg/d IV/IM; not to exceed 125 mg/d
Infants and children: 50-75 mg/kg/d IV/IM divided q12h; not to exceed 2 g/d
ContraindicationsDocumented hypersensitivity
InteractionsProbenecid may increase ceftriaxone levels; coadministration with ethacrynic acid, furosemide, and aminoglycosides may increase nephrotoxicity
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsAdjust dose in severe renal insufficiency (high doses may cause CNS toxicity); superinfections and promotion of nonsusceptible organisms may occur with prolonged use or repeated therapy; caution in breastfeeding

Drug NameTetracycline (Sumycin)
DescriptionTreats gram-positive and gram-negative organisms as well as mycoplasmal, chlamydial, and rickettsial infections. Inhibits bacterial protein synthesis by binding with 30S and, possibly, 50S ribosomal subunits.
Adult Dose250-500 mg PO q6h
Mild-to-moderate infections: 500 mg PO bid or 250 mg PO qid for 7-14 d
Severe infections: 500 mg PO qid for 7-14 d
Pediatric Dose<8 years: Not recommended
>8 years: 25-50 mg/kg/d PO divided qid
ContraindicationsDocumented hypersensitivity; severe hepatic dysfunction
InteractionsBioavailability decreases with antacids containing aluminum, calcium, magnesium, iron, or bismuth subsalicylate; can decrease effects of PO contraceptives, causing breakthrough bleeding and increased risk of pregnancy; tetracyclines can increase hypoprothrombinemic effects of anticoagulants
PregnancyD - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
PrecautionsPhotosensitivity may occur with prolonged exposure to sunlight or tanning equipment; reduce dose in renal impairment; consider drug serum level determinations in prolonged therapy; tetracycline use during tooth development (last one half of pregnancy through age 8 y) can cause permanent discoloration of teeth; Fanconilike syndrome may occur with outdated tetracyclines

Drug Category: Vaccines and immune globulins

These agents provide active and passive immunization and increase resistance to infection.

Drug NameTetanus toxoid
DescriptionThe immunizing agent of choice for most adults and children >7 y is tetanus and diphtheria toxoids (Td). Necessary to administer booster doses to maintain tetanus immunity throughout life. Patients who are pregnant should receive only tetanus toxoid, not a diphtheria antigen-containing product. In children and adults, may administer into deltoid or midlateral thigh muscles. In infants, preferred site of administration is the mid thigh laterally.
Adult DosePrimary immunization: 0.5 mL IM, give 2 injections 4-8 wk apart and a third dose 6-12 mo after second injection
Booster dose: 0.5 mL q10y
Pediatric Dose<7 years: Assure primary immunization with DTP and DTaP has been completed, if incomplete, administer vaccine series according to CDC guidelines
>7 years: Administer as in adults; Tdap is the preferred vaccine for adolescents (10-18 y)
ContraindicationsDocumented hypersensitivity; history of any type of neurologic symptoms or signs following administration of this product; FDA recommends that elective tetanus immunization be deferred during any outbreak of poliomyelitis because tetanus toxoid injections are an important cause of provocative poliomyelitis
InteractionsPatients receiving immunosuppressants, including corticosteroids or radiation therapy, may remain susceptible despite immunization due to poor immune response; cimetidine may enhance or augment delayed-hypersensitivity responses to skin-test antigens; avoid concurrent use of medication with systemic chloramphenicol because it may impair amnestic response to tetanus toxoid; concurrent use of tetanus immune globulin may delay development of active immunity by several days (interaction is nevertheless clinically insignificant and does not preclude its concurrent use)
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsDo not use to treat actual tetanus infections, or for immediate prophylaxis of unimmunized individuals (instead use tetanus antitoxin, preferably human tetanus immune globulin); diminished antibody response to active immunization may be seen in patients receiving immunosuppressive therapy; better to defer primary diphtheria immunization until immunosuppressive therapy discontinued; routine immunization of symptomatic and asymptomatic HIV-infected persons is recommended

Drug NameRabies vaccine (Imovax, RabAvert)
DescriptionInactivated form of virus grown in primary cultures of chicken fibroblasts; offers active immunity and, when used in combination with human rabies immune globulin (HRIG) and local wound treatment, protects postexposure patients of all age groups; also used for preexposure immunization in both primary series and booster dose.
Fourteen days after initiating immunization series, antirabies antibody titers reach levels well above minimal protective level of 0.5 IU/mL.
Adult DosePreexposure immunization: 1 mL IM days 0, 3, 7, 14, and 28, and then q2-5y depending on antibody titers
Postexposure prophylaxis (previously unvaccinated patients):
Administer RIG (20 IU/kg) as soon as possible after exposure, and a total of 5 IM doses each 1 mL on days 0, 3, 7, 14, and 28
Previously immunized patients (documented titers): IM doses days 0 and 3 (one dose each day); do not administer RIG
Pediatric DoseAdminister as in adults
ContraindicationsNone reported for postexposure immunization (if alternative products are not available, caution in persons known to be sensitive to neomycin, amphotericin B, chlortetracycline, processed bovine gelatin, and chicken protein because trace amounts of these products may be present in the vaccine)
InteractionsCorticosteroids, antimalarials, and other immunosuppressive agents may reduce protective efficacy of vaccine; persons receiving immunosuppressive therapy should receive RIG (3 doses/mL each) IM
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsCaution in documented hypersensitivity (may pretreat such patients with antihistamines); never inject rabies vaccine in gluteal area; epinephrine injection (1:1000), volume replacement, oxygen, and corticosteroids must be immediately available to counteract anaphylactic reactions that may occur

Drug NameRabies immune globulin (BayRab, Imogam)
DescriptionProvides passive protection to individuals exposed to rabies virus. About one half the dose should be administered into and around the bite wound as much as possible (given anatomic constraints), and the rest given IM at a site remote from the vaccine administration area, in the gluteal or deltoid muscle.
Adult Dose20 IU/kg; most or all of solution is infiltrated around the wound; any remaining solution should be administered IM in the gluteus once after exposure, preferably with first dose of vaccine; not to exceed 20 IU/kg
Pediatric DoseAdminister as in adults
ContraindicationsDocumented hypersensitivity; to prevent interference with a maximum active immunity from rabies vaccine, do not administer in repeated doses once the rabies vaccine treatment has been initiated
InteractionsThrough an antigen-antibody antagonism, RIG may diminish antibody response to MMR vaccine; should administer live virus vaccines 14-30 d before or 6-12 wk after immune globulin administration; antibody response to rabies vaccine may be delayed if administered simultaneously with rabies immunoglobulins
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsCaution in thrombocytopenia or bleeding disorders



Further Inpatient Care

  • Patients who require inpatient care include those with airway compromise, hemodynamic instability, penetrating skull injury, or severe soft tissue injuries. Patients with wound avulsion with tissue loss as well as patients with open fractures or exposed bone typically are admitted.
  • Appropriate surgical subspecialties should be involved in treating patients admitted to the hospital. Decisions to incise, drain, and explore tissue should be made after surgical consultation.
  • Patients who may not be compliant with outpatient antibiotic therapy may require admission. Patients who have developed signs of infection may benefit from admission.
  • If osteomyelitis is suspected despite normal radiography findings, consider a bone scan.
  • Patients with severe injuries may require several wound debridements in the operating room.
  • Patients may develop hypovolemic shock or septic shock; these patients should be treated appropriately with isotonic crystalloids and pressors as indicated.

Further Outpatient Care

  • Follow-up care is necessary within 24-48 hours for all bite wounds because of risk of infection.

Transfer

  • Transfer patients who are hemodynamically unstable, have airway compromise, or have massive trauma to a tertiary care center.

Deterrence/Prevention

  • Pet owners should watch animals when children are present. Children should be discouraged from approaching animals, especially when the animal is not the family pet. Children should avoid animals that are eating.
  • Citizens should insist on leash laws, and pet owners should keep their animals on a leash.
  • Clinicians can educate parents about the potential dangers of certain breeds and the need to be vigilant if they own a pet.

Complications

  • Meningitis
  • Sepsis
  • Septic arthritis
  • Osteomyelitis
  • Cellulitis
  • Wound infection
  • Facial/neck deformities
  • Limb deformities
  • Limb loss

Prognosis

  • Most patients with animal bites have a good-to-excellent prognosis.

Patient Education

  • Patients and their families should receive instructions that clearly outline the signs of infection.
  • Inform patients of the risk of infection as a consequence of the animal bite despite treatment with irrigation and antibiotics.
  • Emphasize the need for follow-up care as well as the need to receive immediate medical attention if signs of infection develop.
  • For excellent patient education resources, visit eMedicine's Bites and Stings Center and Bacterial and Viral Infections Center. Also, see eMedicine's patient education articles Animal Bites and Rabies.



Medical/Legal Pitfalls

  • Failure to consider the possibility of skull penetration
  • Failure to consider the possibility of inoculation of bacteria into a joint space
  • Improperly closing wounds (eg, cat bite to the hand)
  • Failure to adequately document the patient's history
  • Failure to adequately document treatment (eg, irrigation, antibiotic use)
  • Failure to report the injury to police or the local animal control agency
  • Failure to note any compromise of motor nerves, sensory nerves, or circulation
  • Failure to consider hypovolemia in patients with extensive wounds

Special Concerns

  • If the animal is a family pet, it may attack the child again. Consider discussing the removal of the pet with the family.
  • Dogs that are left off a leash and have bitten individuals constitute a menace to the community. Dogs should always be on a leash. Aggressive dogs may require a muzzle.



Media file 1:  The devastating damage sustained by a preadolescent male during a pit bull attack. Almost lost in this photograph is the soft tissue damage to this victim's thigh. This patient required 2 units of O- blood and several liters of isotonic crystalloid. Repair of these wounds required a pediatric surgeon, an experienced orthopedic surgeon, and a plastic surgeon. Attacks such as these have caused a movement in some areas of the country to ban pit bulls.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 2:  Massive soft tissue damage of the right leg caused by a pit bull attack. This patient was transferred to a level one pediatric trauma center for care. At times, staff members may need counseling after caring for savagely mauled patients.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 3:  Massive soft tissue damage of the lower left leg caused by a pit bull attack. Most of the fatalities from dog bites are children. Rottweilers and pit bulls are responsible for about 60% of fatalities.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 4:  A different angle of the patient in Image 3 showing the massive soft tissue damage to this child's left lower leg. Pit bull attacks are not rare.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 5:  Wounds to the left arm inflicted during a pit bull attack. This young patient was also bitten once on the left side of his face.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo



  1. Brook I. Management of human and animal bite wounds: an overview. Adv Skin Wound Care. May 2005;18(4):197-203. [Medline].
  2. Stefanopoulos PK, Tarantzopoulou AD. Facial bite wounds: management update. Int J Oral Maxillofac Surg. Jul 2005;34(5):464-72. [Medline].
  3. Brogan TV, Bratton SL, Dowd MD, Hegenbarth MA. Severe dog bites in children. Pediatrics. Nov 1995;96(5 Pt 1):947-50. [Medline].
  4. CID. Report of the committee on infectious diseases. In: Red Book. 24th ed. American Academy of Pediatrics; 1997:122-6.
  5. Dire DJ. Cat bite wounds: risk factors for infection. Ann Emerg Med. Sep 1991;20(9):973-9. [Medline].
  6. Dire DJ. Emergency management of dog and cat bite wounds. Emerg Med Clin North Am. Nov 1992;10(4):719-36. [Medline].
  7. Dos Santos LM, Abramo TJ, Schunk JE. Dog bites. Pediatr Emerg Care. Oct 1995;11(5):313-6. [Medline].
  8. Fleisher GR. The management of bite wounds. N Engl J Med. Jan 14 1999;340(2):138-40. [Medline].
  9. Jones N, Khoosal M. Infected dog and cat bites. N Engl J Med. Jun 10 1999;340(23):1841; discussion 1842. [Medline].
  10. Litwin CM. Pet-transmitted infections: diagnosis by microbiologic and immunologic methods. Pediatr Infect Dis J. Sep 2003;22(9):768-77. [Medline].
  11. Quinlan KP, Sacks JJ. Hospitalizations for dog bite injuries. JAMA. Jan 20 1999;281(3):232-3. [Medline].
  12. Talan DA, Citron DM, Abrahamian FM, et al. Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group. N Engl J Med. Jan 14 1999;340(2):85-92. [Medline].

Animal Bites excerpt

Article Last Updated: Jul 14, 2008